Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Check-Cap Ltd. stock logo
CHEK
Check-Cap
$0.79
-1.5%
$0.82
$0.56
$3.04
$4.62M0.19378,727 shs4,672 shs
IRIDEX Corporation stock logo
IRIX
IRIDEX
$1.03
+2.5%
$1.00
$0.78
$2.41
$17.21M0.5752,317 shs16,844 shs
Nephros Inc. stock logo
NEPH
Nephros
$3.69
-1.1%
$3.16
$1.36
$5.00
$39.11M1.0918,547 shs17,890 shs
NexGel, Inc. stock logo
NXGL
NexGel
$2.68
-1.5%
$2.43
$2.00
$5.10
$20.50M0.5970,690 shs5,164 shs
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Check-Cap Ltd. stock logo
CHEK
Check-Cap
-0.94%+5.58%-0.45%+20.30%-58.85%
IRIDEX Corporation stock logo
IRIX
IRIDEX
+3.32%+8.99%+0.55%+4.60%-51.13%
Nephros Inc. stock logo
NEPH
Nephros
-4.11%-6.28%-2.10%+87.44%+82.84%
NexGel, Inc. stock logo
NXGL
NexGel
+1.49%+3.82%+14.29%+4.62%+21.97%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Check-Cap Ltd. stock logo
CHEK
Check-Cap
0.4648 of 5 stars
0.05.00.00.00.00.00.6
IRIDEX Corporation stock logo
IRIX
IRIDEX
0.4439 of 5 stars
0.04.00.00.00.61.70.0
Nephros Inc. stock logo
NEPH
Nephros
1.6244 of 5 stars
3.53.00.00.00.60.80.0
NexGel, Inc. stock logo
NXGL
NexGel
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Check-Cap Ltd. stock logo
CHEK
Check-Cap
0.00
N/AN/AN/A
IRIDEX Corporation stock logo
IRIX
IRIDEX
0.00
N/AN/AN/A
Nephros Inc. stock logo
NEPH
Nephros
3.00
Buy$5.0035.50% Upside
NexGel, Inc. stock logo
NXGL
NexGel
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Check-Cap Ltd. stock logo
CHEK
Check-Cap
N/AN/AN/AN/A$4.05 per shareN/A
IRIDEX Corporation stock logo
IRIX
IRIDEX
$48.67M0.35N/AN/A$0.13 per share7.88
Nephros Inc. stock logo
NEPH
Nephros
$14.16M2.76$0.02 per share194.39$0.81 per share4.56
NexGel, Inc. stock logo
NXGL
NexGel
$8.69M2.36N/AN/A$0.90 per share2.98
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Check-Cap Ltd. stock logo
CHEK
Check-Cap
-$17.57M-$3.00N/AN/AN/AN/AN/AN/A
IRIDEX Corporation stock logo
IRIX
IRIDEX
-$8.91M-$0.43N/AN/A-14.61%-290.57%-22.86%8/6/2025 (Estimated)
Nephros Inc. stock logo
NEPH
Nephros
$70K$0.0752.72N/A5.16%9.43%7.20%8/6/2025 (Estimated)
NexGel, Inc. stock logo
NXGL
NexGel
-$3.28M-$0.45N/AN/A-30.80%-54.95%-27.84%8/18/2025 (Estimated)

Latest CHEK, NXGL, NEPH, and IRIX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/15/2025Q1 2025
Nephros Inc. stock logo
NEPH
Nephros
-$0.0050$0.0526+$0.0576$0.05$3.67 million$4.88 million
5/13/2025Q1 2025
IRIDEX Corporation stock logo
IRIX
IRIDEX
-$0.10-$0.10N/A-$0.10$12.10 million$11.90 million
5/13/2025Q1 2025
NexGel, Inc. stock logo
NXGL
NexGel
-$0.10-$0.09+$0.01-$0.09$2.73 million$2.81 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Check-Cap Ltd. stock logo
CHEK
Check-Cap
N/AN/AN/AN/AN/A
IRIDEX Corporation stock logo
IRIX
IRIDEX
N/AN/AN/AN/AN/A
Nephros Inc. stock logo
NEPH
Nephros
N/AN/AN/AN/AN/A
NexGel, Inc. stock logo
NXGL
NexGel
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Check-Cap Ltd. stock logo
CHEK
Check-Cap
N/AN/AN/A
IRIDEX Corporation stock logo
IRIX
IRIDEX
4.28
1.95
1.27
Nephros Inc. stock logo
NEPH
Nephros
N/A
5.92
4.64
NexGel, Inc. stock logo
NXGL
NexGel
0.15
1.88
1.15

Institutional Ownership

CompanyInstitutional Ownership
Check-Cap Ltd. stock logo
CHEK
Check-Cap
1.07%
IRIDEX Corporation stock logo
IRIX
IRIDEX
20.10%
Nephros Inc. stock logo
NEPH
Nephros
41.10%
NexGel, Inc. stock logo
NXGL
NexGel
2.21%

Insider Ownership

CompanyInsider Ownership
Check-Cap Ltd. stock logo
CHEK
Check-Cap
0.48%
IRIDEX Corporation stock logo
IRIX
IRIDEX
7.40%
Nephros Inc. stock logo
NEPH
Nephros
6.70%
NexGel, Inc. stock logo
NXGL
NexGel
20.55%
CompanyEmployeesShares OutstandingFree FloatOptionable
Check-Cap Ltd. stock logo
CHEK
Check-Cap
805.85 million5.82 millionNot Optionable
IRIDEX Corporation stock logo
IRIX
IRIDEX
12016.79 million15.55 millionOptionable
Nephros Inc. stock logo
NEPH
Nephros
3010.60 million9.89 millionNot Optionable
NexGel, Inc. stock logo
NXGL
NexGel
107.65 million6.08 millionNot Optionable

Recent News About These Companies

NEXGEL, Inc. (NXGL) Q1 2025 Earnings Call Transcript
NEXGEL Reports First Quarter 2025 Financial Results
1NXGL : A Peek at NexGel's Future Earnings
NEXGEL Reports Record Revenue Growth in 2024
NEXGEL, Inc. (NXGL) Q4 2024 Earnings Call Transcript

New MarketBeat Followers Over Time

Media Sentiment Over Time

Check-Cap stock logo

Check-Cap NASDAQ:CHEK

$0.79 -0.01 (-1.55%)
As of 02:03 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.

IRIDEX stock logo

IRIDEX NASDAQ:IRIX

$1.02 +0.03 (+2.51%)
As of 02:08 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.

Nephros stock logo

Nephros NASDAQ:NEPH

$3.69 -0.04 (-1.07%)
As of 02:15 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, cysts, particulates, and scale build-up in downstream equipment. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.

NexGel stock logo

NexGel NASDAQ:NXGL

$2.68 -0.04 (-1.47%)
As of 02:12 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

NEXGEL, Inc. manufactures high water content, electron beam cross-linked, and aqueous polymer hydrogels and gels. Its products are used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company was formerly known as AquaMed Technologies, Inc. and changed its name to NEXGEL, Inc. in November 2019. The company was incorporated in 2009 and is based in Langhorne, Pennsylvania.